Michael E. Hepperle
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 16
- Cytokine Signaling Pathways and Interactions 4
-
- Synthetic Organic Chemistry Methods 8
- Co-authors
- Gunda I. Georg (15 shared papers)Yajun Xu (6 shared papers)Danyi Wen (5 shared papers)Yuhua Nong (3 shared papers)Louis M. Staudt (2 shared papers)Lenny Dang (2 shared papers)Richard Eric Davis (2 shared papers)Julian Adams (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)The Journal of Organic Chemistry (2 papers)Tetrahedron Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Biochemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Michael E. Hepperle
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 85
- Oncology 726
- Cancer Research 342
- Pathology and Forensic Medicine 275
- Pharmacology 227
- Organic Chemistry 403
Countries citing papers authored by Michael E. Hepperle
This map shows the geographic impact of Michael E. Hepperle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Hepperle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Hepperle more than expected).
Fields of papers citing papers by Michael E. Hepperle
This network shows the impact of papers produced by Michael E. Hepperle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Hepperle. The network helps show where Michael E. Hepperle may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Hepperle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Taxol®: science and applications. | 1995 | 321 |
| 2 | Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. | 2005 | 282 |
| 3 | 2005 | 209 | |
| 4 | 2006 | 107 | |
| 5 | 1998 | 77 | |
| 6 | 2006 | 73 | |
| 7 | 2006 | 69 | |
| 8 | 2006 | 43 | |
| 9 | 1993 | 41 | |
| 10 | 1994 | 38 | |
| 11 | 1996 | 37 | |
| 12 | 1994 | 34 | |
| 13 | 2009 | 32 | |
| 14 | 2002 | 27 | |
| 15 | 2009 | 26 | |
| 16 | 1999 | 24 | |
| 17 | 1997 | 23 | |
| 18 | 1999 | 21 | |
| 19 | 1995 | 19 | |
| 20 | 2010 | 19 |
About Michael E. Hepperle
Michael E. Hepperle is a scholar working on Oncology, Organic Chemistry, Cancer Research, Pharmacology and Cell Biology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Synthetic Organic Chemistry Methods (8 papers), NF-κB Signaling Pathways (5 papers), Melanoma and MAPK Pathways (5 papers), 14-3-3 protein interactions (4 papers), Microtubule and mitosis dynamics (4 papers), Microbial Natural Products and Biosynthesis (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Oncology (726 citations), Cancer Research (342 citations), Pathology and Forensic Medicine (275 citations), Pharmacology (227 citations) and Organic Chemistry (403 citations). Michael E. Hepperle has collaborated with scholars based in United States. Frequent co-authors include Gunda I. Georg, Yajun Xu, Danyi Wen, Yuhua Nong, Louis M. Staudt, Lenny Dang, Richard Eric Davis, Julian Adams, Lloyd T. Lam and Maria Hottelet. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Tetrahedron Letters, Journal of Pharmacology and Experimental Therapeutics and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.